Skip to Content
Merck
CN
  • Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD.

Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD.

Gut (2014-06-28)
Parambir S Dulai, Corey A Siegel, Jean-Frederic Colombel, William J Sandborn, Laurent Peyrin-Biroulet
PMID24970900
MATERIALS
Product Number
Brand
Product Description
A4638
Sigma-Aldrich
Azathioprine, ≥98%
852678
Sigma-Aldrich
6-Mercaptopurine monohydrate, 98%
A1500000
Azathioprine, European Pharmacopoeia (EP) Reference Standard
PHR1282
Supelco
Azathioprine, Pharmaceutical Secondary Standard; Certified Reference Material